Companies: 10,795·Total market cap: $144.5T
Viatris Inc.

Viatris Inc.

VTRSNASDAQHealthcare● Active
$15.88
$-0.02(-0.13%)
Market Cap$18.5B
P/E Ratio—
52W High$17.53
52W Low$8.44
SEC Filings

Viatris Inc. (VTRS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001792044 · VTRS · NASDAQ · as of Jun 8, 2026

Filing snapshot

520
Total Filings
8-K
Latest Form
2026-05-15
Most Recent
1980
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001792044 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-26
Fiscal Year End
Feb 26, 2026
Accession No.
0001792044-26-000013
Primary Document
vtrs-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001792044 · Accession 0001792044-26-000013

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-15Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-05
View
8-KCurrent Report
8-K
2026-05-04
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-30
View
ARSARS
ARS
2026-04-02
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-02
View
DEF 14AProxy Statement
DEF 14A
2026-04-02
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-27
View
3/AInitial Statement of Beneficial Ownership (Amended)
FORM 3/A
2026-03-10
View
10-KAnnual Report
10-K
2026-02-26
View
8-KCurrent Report
8-K
2026-02-26
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-04
View
Showing 1–15 of 230 filingsForm 4 / 144 hidden· 520 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001792044  |  Exchange: NASDAQ · Healthcare

Viatris Inc. (NASDAQ: VTRS) has submitted 520 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1980. As a Healthcare sector company with CIK 0001792044, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Viatris Inc.'s most comprehensive regulatory disclosure. The most recent Viatris Inc. 10-K was filed on 2026-02-26 for fiscal year ending 2026. Historical VTRS 10-K annual reports are available from 2019 through 2026.

Investors researching Viatris Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ROIV SEC Filings →EXAS SEC Filings →MRNA SEC Filings →NBIX SEC Filings →BBIO SEC Filings →IONS SEC Filings →ELAN SEC Filings →RDY SEC Filings →
→ VTRS Financials→ VTRS Earnings→ VTRS Insider Trades

Frequently Asked Questions

VTRS SEC Filings · 8 questions

Viatris Inc. (VTRS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 520 filings and access original documents at no cost. Viatris Inc.'s CIK is 0001792044.

VTRS SEC filingsViatris Inc. SEC documentsfind VTRS 10-K